Search filters

List of works by Roisin E. O'Cearbhaill

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

scientific article published on 22 April 2016

A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen

scientific article published on 15 May 2019

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

scientific article published on 17 January 2020

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

scientific article published on 04 June 2019

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer

scientific article published on 28 March 2015

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

scientific article published on 30 October 2020

A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer

scientific article published on 07 November 2019

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study

scientific article

A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission:

scientific article published on 22 October 2019

Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer

scientific article published on 22 December 2019

Authors' reply to Drs. Khattak and Martin

BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer

scientific article published on 16 June 2020

Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status

scientific article published on 18 May 2019

COVID-19 outcomes of patients with gynecologic cancer in New York City

scientific article published on 30 July 2020

Cancer Clinical Investigators Should Converge with Pharmacometricians

scientific article published on 27 June 2019

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery

scientific article published on 01 January 2020

Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center

scientific article published on 14 May 2016

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

scientific article published on 01 August 2018

Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13

scientific article published on 03 August 2016

Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020)

scientific article published on 28 May 2020

Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer

scientific article published on 16 January 2017

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

scientific article published on 22 November 2018

Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study

scientific article published on 29 December 2020

Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies

scientific article published on June 2013

Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statement

scientific article published on 07 August 2020

Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center

scientific article published on 08 May 2019

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer

scientific article published in September 2023

Germline drivers of gynecologic carcinosarcoma (2274)

scientific article published in September 2023

Identifying Clinical Improvement in Consolidation Single-Arm Phase 2 Trials in Patients With Ovarian Cancer in Second or Greater Clinical Remission ⬇️

scientific article published on January 1, 2012

Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma

scientific article published on 13 November 2011

Impact of Provider Imaging Practices on Survival Outcomes in Advanced Ovarian Cancer

scientific article published on 01 April 2020

Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer

scientific article published on 16 August 2020

Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer

scientific article published on 29 October 2020

Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection

scientific article published on 25 September 2020

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers

scientific article published on 01 June 2018

Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center

scientific article

Intraperitoneal chemotherapy in older women with epithelial ovarian cancer

article

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

scientific article published in March 2023

Is It Time to Centralize Ovarian Cancer Care in the United States?

scientific article published on 28 October 2015

It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer

article

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

scientific article published on 20 April 2022

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

scientific article published in April 2023

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

scientific article

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

scientific article published on 28 September 2019

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

scientific article published on 14 March 2019

Optimal management of uterine leiomyosarcoma

scientific article published in February 2010

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

scientific article

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

scientific article published in January 2024

Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer

scientific article published on 02 September 2018

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

scientific article published on 27 December 2019

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

scientific article published on 07 January 2020

Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy (530)

scientific article published in August 2022

Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

scientific article published on 26 October 2020

Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management (100)

scientific article published in August 2022

Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

scientific article published in March 2023

Primary osteosarcoma of the uterus with cardiac and pulmonary metastases

scientific article published on October 2014

Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.

scientific article published on May 2015

Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer

scientific article

Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy

scientific article published on 09 December 2020

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

scientific article published on 01 June 2020

Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience

article

Secondary surgical resection for patients with recurrent uterine leiomyosarcoma

scientific article published on 12 June 2019

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

scientific article published on 14 August 2019

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis

scientific article published on 21 February 2012

Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study

scientific article published on 16 November 2020

Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study

scientific article published on 05 June 2020

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors

scientific article published in February 2023

The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer

article

The Experience of Being Aware of Disease Status in Women with Recurrent Ovarian Cancer: A Phenomenological Study

scientific article published on 08 November 2018

The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment

scientific article

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors

scientific article published on 24 November 2009

Using PARP Inhibitors in Advanced Ovarian Cancer

scientific article published on 01 July 2018

Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy

scientific article published on 02 June 2020

Paulina is supported by:

About Paulina

Help